SARS-CoV-2 infection Clinical Trials

24 recruitingLast updated: May 11, 2026

There are 24 actively recruiting sars-cov-2 infection clinical trials across 50 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3. Top locations include Nashville, Tennessee, United States, Boston, Massachusetts, United States, Aurora, Colorado, United States. Updated daily from ClinicalTrials.gov.


SARS-CoV-2 infection Trials at a Glance

24 actively recruiting trials for sars-cov-2 infection are listed on ClinicalTrialsFinder across 6 cities in 50 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Nashville, Boston, and Aurora. Lead sponsors running sars-cov-2 infection studies include Boston University, VA Office of Research and Development, and Vanderbilt University Medical Center.

Browse sars-cov-2 infection trials by phase

Treatments under study

About SARS-CoV-2 infection Clinical Trials

Looking for clinical trials for SARS-CoV-2 infection? There are currently 19 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new SARS-CoV-2 infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about SARS-CoV-2 infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting

Cognitive-Sensorimotor Function in Long-COVID

Post-acute Sequelae of SARS-CoV-2 Infection
VA Office of Research and Development136 enrolled1 locationNCT06850350
Recruiting
Not Applicable

NC Testing in LC & POTS

Postural Orthostatic tachycardia SyndromePost-acute Sequelae of SARS-CoV-2 Infection
University of Calgary100 enrolled1 locationNCT05914649
Recruiting
Phase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

SARS-CoV-2 infectionCOVID-19Long COVID+1 more
Wes Ely550 enrolled16 locationsNCT06631287
Recruiting
Not Applicable

Exercise in Child Health

SARS-CoV-2 infectionCystic FibrosisSickle Cell Disease
University of California, Irvine240 enrolled1 locationNCT05359991
Recruiting
Phase 1

T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients

SARS-CoV-2 infection
Children's National Research Institute24 enrolled2 locationsNCT05141058
Recruiting
Phase 2

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

SARS-CoV-2 infectionPost-Acute COVID-19 SyndromeLong Covid19+1 more
Vanderbilt University Medical Center50 enrolled1 locationNCT07189936
Recruiting

Predictors of Post-COVID-19 Clinical and Cognitive Consequences

Obstructive Sleep ApneaPost-acute Sequelae of SARS-CoV-2 Infection
VA Office of Research and Development200 enrolled1 locationNCT06291870
Recruiting
Not Applicable

Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

SARS-CoV-2 infectionPost-Acute COVID-19 SyndromeLong COVID+1 more
Vanderbilt University Medical Center60 enrolled1 locationNCT05421208
Recruiting
Not Applicable

Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

Post-acute Sequelae of SARS-CoV-2 Infection
University of Colorado, Denver30 enrolled1 locationNCT05566483
Recruiting

Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India

perinatal morbiditySARS-CoV-2 infectionCOVID-19+3 more
Boston University10,000 enrolled2 locationsNCT06168019
Recruiting
Phase 1Phase 2

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

SARS-CoV-2 infectionCOVID-19
Kara Chew80 enrolled2 locationsNCT06810934
Recruiting
Phase 2

Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients

Renal transplantSARS-CoV-2 infectionCOVID-19
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia15 enrolled1 locationNCT07197164
Recruiting

NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19

SARS-CoV-2 infectionCOVID-19
NYU Langone Health350 enrolled1 locationNCT05292274
Recruiting

COVID-19 Transmission and Morbidity in Malawi

SARS-CoV-2 infectionSARS CoV 2 Vaccination
Boston University1,500 enrolled2 locationsNCT05973084
Recruiting

CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2

SARS-CoV-2 infectionCOVID-19
Columbia University1,000 enrolled1 locationNCT05467930
Recruiting
Not Applicable

Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2

CoronavirusSARS-CoV-2 infectionCOVID-19
Centre Hospitalier Universitaire de Nīmes250 enrolled2 locationsNCT06099795
Recruiting
Not Applicable

Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19

SARS-CoV-2 infectionCOVID-19Anosmia+2 more
Université du Québec à Trois-Rivières70 enrolled1 locationNCT05384561
Recruiting

SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study

SARS-CoV-2 infectionKidney Transplant Infection
Helio Tedesco Silva Junior500 enrolled1 locationNCT04494776
Recruiting

SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia

SARS-CoV-2 infectionCOVID-19 RecurrentCOVID-19 Breakthrough
Michael Hoelscher1,000 enrolled2 locationsNCT06435403
Recruiting

COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics

SARS-CoV-2 infectionCOVID-19
Direction Centrale du Service de Santé des Armées1,188 enrolled1 locationNCT05892549